Pteryxin suppresses osteoclastogenesis and prevents bone loss via inhibiting the MAPK/Ca2+ signaling pathways mediated by ROS
Article in Biomedicine & Pharmacotherapy (June 2023)
The most recent citing publications are shown below. View all 27 publications that cite this research output on Dimensions.
Casticin suppresses RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating the AKT/ERK and NF-κB signaling pathways
Article in International Journal of Molecular Medicine (April 2023)
Lonafarnib Inhibits Farnesyltransferase via Suppressing ERK Signaling Pathway to Prevent Osteoclastogenesis in Titanium Particle-Induced Osteolysis
Article in Frontiers in Pharmacology (March 2022)